- The FDA approves an assay developed by Grifols (OTCPK:GIKLY) used to screen donated blood for the presence of four species of malaria-like parasites called Babesia, transmitted by certain ticks. The highest number of infections in the U.S. occur in the Northeast, Wisconsin and Minnesota.
- The test is performed on the automated Procleix Panther system.
FDA OKs Grifols test for Babesia parasites in blood screening
Recommended For You
More Trending News
About GIKLY Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
GIKLY | - | - |
Grifols, S.A. |